PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2026-03-07

Date Title Company
07-Mar-2026 U.S. FDA Approves Bristol Myers Squibb’s Sotyktu® (deucravacitinib) for the Treatment of Adults with Active Psoriatic Arthritis Businesswire
07-Mar-2026 Investor Notice: Robbins LLP Informs Investors of the Soleno Therapeutics, Inc. Class Action Lawsuit Businesswire